ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
Dow Jones
42,992.21
-0.77%
Brent Oil
73.785
0.22%
Bitcoin
94,008.64
0.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Palisade Bio Inc (PALI) Quote

Palisade Bio Inc

Palisade Bio Inc (PALI)

Palisades Goldcorp Ltd
1.67
-0.10
(-5.65%)
Closed December 29 4:00PM
Delayed by 15 minutes
1.70
0.03
(1.80%)
After Hours: 7:58PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.70
Bid
1.70
Ask
1.80
Volume
169,116
1.63 Day's Range 1.7692
1.38 52 Week Range 22.35
Market Cap
2.26M
Previous Close
1.77
Open
1.74
Last Trade
1600
@
1.7
(formt)
Last Trade Time
Financial Volume
$ 285,294
VWAP
1.687
Average Volume (3m)
1,340,924
Shares Outstanding
1,329,516
Dividend Yield
-
PE Ratio
-0.16
Earnings Per Share (EPS)
-9.25
Revenue
250k
Net Profit
-12.3M

About Palisade Bio Inc

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.palisadebio.com.
Headquarters
Camden, Delaware, USA
Founded
-
Palisade Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PALI. The last closing price for Palisade Bio was $1.77. Over the last year, Palisade Bio shares have traded in a share price range of $ 1.38 to $ 22.35.

Palisade Bio currently has 1,329,516 shares outstanding. The market capitalization of Palisade Bio is $2.35 million. Palisade Bio has a price to earnings ratio (PE ratio) of -0.16.

Ask ADVFN Intelligence (AI)

PALI Latest News

More News

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 17 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 17 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 17 2024
Edgar (US Regulatory)

Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board

Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) --  Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

December 17 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

December 17 2024
Edgar (US Regulatory)

Form 8-K - Current report

December 16 2024
Edgar (US Regulatory)

Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules

Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on...

December 13 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

December 13 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

December 13 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

December 13 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.09-5.027932960891.791.861.671146481.7459629CS
4-0.79-31.72690763052.493.31.3839093062.31004384CS
12-1.86-52.24719101123.564.3181.3813409242.34561074CS
26-2.82-62.3893805314.524.891.386556482.42545052CS
52-7.255-81.01619207158.95522.351.3812822878.85654719CS
156-1250.8-99.86427145711252.512601.381920429128.38186659CS
260-6748.3-99.974814814867508182.51.381700417334.57988275CS

PALI - Frequently Asked Questions (FAQ)

What is the current Palisade Bio share price?
The current share price of Palisade Bio is $ 1.70
How many Palisade Bio shares are in issue?
Palisade Bio has 1,329,516 shares in issue
What is the market cap of Palisade Bio?
The market capitalisation of Palisade Bio is USD 2.35M
What is the 1 year trading range for Palisade Bio share price?
Palisade Bio has traded in the range of $ 1.38 to $ 22.35 during the past year
What is the PE ratio of Palisade Bio?
The price to earnings ratio of Palisade Bio is -0.16
What is the cash to sales ratio of Palisade Bio?
The cash to sales ratio of Palisade Bio is 8.09
What is the reporting currency for Palisade Bio?
Palisade Bio reports financial results in USD
What is the latest annual turnover for Palisade Bio?
The latest annual turnover of Palisade Bio is USD 250k
What is the latest annual profit for Palisade Bio?
The latest annual profit of Palisade Bio is USD -12.3M
What is the registered address of Palisade Bio?
The registered address for Palisade Bio is 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934
What is the Palisade Bio website address?
The website address for Palisade Bio is www.palisadebio.com.
Which industry sector does Palisade Bio operate in?
Palisade Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
557.72M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.75M
RGTIRigetti Computing Inc
$ 17.08
(10.62%)
298.47M
XTIAXTI Aerospace Inc
$ 0.03935
(-1.63%)
263.01M
QSIQuantum Si Inc
$ 3.585
(66.74%)
250.36M

PALI Discussion

View Posts
Monksdream Monksdream 1 week ago
PALI, under $2
👍️0
INFINITI INFINITI 2 weeks ago
Offering Closed now lets move this bad boy back up $$$$$
👍 1
INFINITI INFINITI 2 weeks ago
Moving back up $$$
👍️0
Helter Skelter Helter Skelter 2 weeks ago
That was radical. Dropped from 2.50 to 2 at the blink of an eye, then halted.
Whatever you do...do not go long this Nasdaq garbage, JMO



If I worked on Wall Street I'd make a Halloween costume mask out of this chart and wear it to work, lol...



$PALI
👍️0
INFINITI INFINITI 2 weeks ago
Public offering 
👍️0
INFINITI INFINITI 2 weeks ago
Halted 
👍️0
Helter Skelter Helter Skelter 3 weeks ago
Picking up steam, closing in on 20 million volume.
May see 100 million on the day if they really spin this puppy...



$PALI
👍️0
Helter Skelter Helter Skelter 3 weeks ago
Offering in PLAY. Let's see how high they can spin her...

...watch the open...👎️😺👍️



I'm thinking they've got to spin her pretty high (50 million plus) on volume to pull in around $5 million in proceeds selling up to 4, 5, 6 million shares...easy if they drop a PR. JMO



👉️ SEC FORM S-1/A

$PALI
👍️0
glenn1919 glenn1919 3 weeks ago
PALI...........................https://stockcharts.com/h-sc/ui?s=PALI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 weeks ago
Started last night. Stay up a little longer before the descent 
👍️0
subslover subslover 3 weeks ago
Someone's fat finger on the buy button this morning😁
👍️0
Helter Skelter Helter Skelter 3 weeks ago
This may blow up to 6 or 7 bucks 😺 (currently 2.75, +96% on 9.2M volume already, 7x OS)

As of November 7, 2024, there were 1,329,516 shares of common stock, $0.01 par value, outstanding.

Stockholders' Equity $6,608,000 / 1,329,516 OS = $4.97 (5 bucks) per share stocholders' equity value.





$PALI
👍️0
frans frans 3 weeks ago
pali 3.25
👍️0
glenn1919 glenn1919 3 weeks ago
pali............................https://stockcharts.com/h-sc/ui?s=pali&p=W&b=5&g=0&id=p86431144783
👍️0
BurgerKing82 BurgerKing82 4 weeks ago
Thoughts on this one?
👍️0
Monksdream Monksdream 4 months ago
PALI 10Q due AUGUST 19
👍️0
Monksdream Monksdream 5 months ago
PALI new 52 week low
👍️0
Monksdream Monksdream 5 months ago
Pump and dump
👍️0
Awl416 Awl416 5 months ago
That was quick LOL
👍️0
Awl416 Awl416 5 months ago
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108
👍️0
Monksdream Monksdream 5 months ago
PALI under $5
👍️0
Monksdream Monksdream 6 months ago
PALI under $5
👍️0
Monksdream Monksdream 7 months ago
PALI under $5
👍️0
tw0122 tw0122 8 months ago
Time to scale out for sure
👍️0
tw0122 tw0122 8 months ago
Boom
👍️0
Monksdream Monksdream 8 months ago
Will it grow legs after 9:30
👍️0
TheFinalCD TheFinalCD 8 months ago
9.11 .....PALI $10 coming fast
👍️0
TheFinalCD TheFinalCD 8 months ago
https://twitter.com/health_stocks/status/1785648381009731796
👍️0
Awl416 Awl416 8 months ago
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
👍️0
Monksdream Monksdream 8 months ago
PALI under $10
👍️0
Awl416 Awl416 8 months ago
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
PALI monster post split
👍️0
Invest-in-America Invest-in-America 8 months ago
PALI: Works great in a TEST TUBE --- wonderful!!! (Pure Home Depot Acetone can kill any bad things in a TEST TUBE too!!! Like Cancer, Parasites, Bacteria, Viruses, inter alia --- especially when the "Scientist" then puts a MATCH to the test tube!!! Ka-booom!! Goodbye ALL bad stuff that afflicts Mankind!!!)
👍️0
Monksdream Monksdream 8 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Awl416 Awl416 8 months ago
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
PALI...POST SPLIT SURGE....IS ITTHE BIG ONE?
👍️0
Monksdream Monksdream 9 months ago
PALI new 52 lo
👍️0
Awl416 Awl416 9 months ago
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
PALI....PICKING UP SPEED NOW AS WE BREAK TGE 7 DOLLA HOLLA
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
PALI...READY BLAST OFF THE SPLIT
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
PALI...POST SPLIT BIO BEAST
👍️0
Monksdream Monksdream 10 months ago
PALI new 52 week lo
👍️0
Monksdream Monksdream 10 months ago
PALI new 52 week low
👍️0
Monksdream Monksdream 11 months ago
PALI new 52 week low
👍️0
Monksdream Monksdream 11 months ago
PALI new 52 week low
👍️0
subslover subslover 11 months ago
That would be fantastic! :)
👍️0
MetaMonster MetaMonster 11 months ago
2$ coming out way
👍️0
subslover subslover 11 months ago
Halted $1.24
👍️0
billionareboysclub billionareboysclub 11 months ago
Halted
👍️0
TimeFades TimeFades 11 months ago
Boom
👍️0

Your Recent History

NASDAQ
PALI
Palisade Bio
BIT
I09303
Intesa Sanpaolo
LSE
WTEF
Wt Us Eff Core
BIT
XTIP
Xtrackers Ii Tips Us Inf...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads